A decision analysis model identifies the interval of efficacy for transarterial chemoembolization (TACE) in cirrhotic patients with hepatocellular carcinoma awaiting liver transplantation.

Source:http://linkedlifedata.com/resource/pubmed/id/17682827

Download in:

View as

General Info

PMID
17682827